In millions, except per share items | Sep-30-22 | Sep-30-21 | Sep-30-20 | Sep-30-19 | Sep-30-18 | Sep-30-17 | Sep-30-16 | Sep-30-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Brooks Semiconductor Solutions Group | | | | | 435.0 | 378.8 | 325.9 | 484.6 |
Brooks Life Science Systems | | | | | | | | 68.1 |
Other | | | | | 196.5 | 148.7 | 108.1 | |
Total revenues [+] | 555.5 | 513.7 | 388.5 | 334.2 | 631.6 | 527.5 | 434.0 | 552.7 |
Products | | | | | | | 335.9 | 457.4 |
Services | | | | | | | 98.1 | 95.3 |
Revenue growth [+] | 8.1% | 32.2% | 16.3% | -47.1% | 19.7% | 21.5% | -21.5% | 14.5% |
Brooks Semiconductor Solutions Group | | | | | 14.8% | 16.2% | -32.8% | 15.5% |
Brooks Life Science Systems | | | | | | | | 7.8% |
Cost of goods sold [+] | 299.9 | 269.9 | 216.4 | 199.6 | 385.5 | 328.6 | 277.3 | 363.6 |
Cost of product sales | | | | | | | 212.0 | 298.3 |
Cost of services | | | | | | | 65.3 | 65.3 |
Gross profit | 255.6 | 243.8 | 172.1 | 134.6 | 246.1 | 198.9 | 156.7 | 189.1 |
Gross margin | 46.0% | 47.5% | 44.3% | 40.3% | 39.0% | 37.7% | 36.1% | 34.2% |
Selling, general and administrative | 252.1 | 252.1 | 190.3 | 163.3 | 167.0 | 141.5 | 119.3 | 115.3 |
Research and development | 27.5 | 22.4 | 17.8 | 17.3 | 46.9 | 39.9 | 44.2 | 52.2 |
Equity in earnings | | | | 6.2 | 6.8 | -0.5 | -1.1 | -0.2 |
EBITDA [+] | 29.7 | 34.6 | 29.6 | 14.6 | 76.3 | 45.2 | 20.1 | 46.6 |
EBITDA growth | -14.3% | 17.1% | 102.5% | -80.9% | 69.0% | 124.3% | -56.8% | 111.9% |
EBITDA margin | 5.3% | 6.7% | 7.6% | 4.4% | 12.1% | 8.6% | 4.6% | 8.4% |
Depreciation | 21.4 | 27.9 | 30.1 | 27.2 | 13.2 | 11.0 | 13.2 | 12.3 |
EBITA | 8.3 | 6.7 | -0.5 | -12.6 | 63.1 | 34.1 | 6.9 | 34.3 |
EBITA margin | 1.5% | 1.3% | -0.1% | -3.8% | 10.0% | 6.5% | 1.6% | 6.2% |
Amortization of intangibles | 32.3 | 37.4 | 35.4 | 27.3 | 24.2 | 17.1 | 14.8 | 12.9 |
EBIT [+] | -24.0 | -30.7 | -35.9 | -39.9 | 38.9 | 17.0 | -7.9 | 21.4 |
EBIT growth | -21.8% | -14.5% | -9.9% | -202.4% | 128.8% | -315.1% | -136.9% | -1564.4% |
EBIT margin | -4.3% | -6.0% | -9.2% | -11.9% | 6.2% | 3.2% | -1.8% | 3.9% |
Non-recurring items | 0.7 | 0.4 | 0.7 | 1.4 | 0.7 | 3.1 | 10.2 | 4.7 |
Interest expense, net [+] | 4.6 | 2.0 | 2.9 | 22.3 | 9.5 | 0.4 | 0.2 | -0.5 |
Interest expense | 4.6 | 2.0 | 2.9 | 22.3 | 9.5 | 0.4 | 0.2 | 0.4 |
Interest income | | | | | | | | 0.9 |
Other income (expense), net | 19.4 | -15.8 | -0.7 | -20.5 | -8.2 | 1.1 | 0.1 | 0.6 |
Pre-tax income | -9.9 | -49.0 | -40.3 | -84.0 | 20.5 | 14.5 | -18.1 | 17.8 |
Income taxes | 1.4 | -20.1 | -13.9 | -22.8 | -47.3 | 3.4 | 66.3 | 3.4 |
Tax rate | | 41.0% | 34.6% | 27.2% | | 23.3% | | 19.3% |
Minority interest | | | | | -0.1 | | | |
Earnings from continuing ops | -2,155.4 | -168.5 | -117.6 | -559.7 | 67.8 | 10.7 | -170.9 | 14.2 |
Earnings from discontinued ops | 2,144.1 | 139.6 | 91.2 | 498.5 | 48.7 | 51.9 | 16.0 | |
Net income | -11.3 | -28.9 | -26.4 | -61.1 | 116.6 | 62.6 | -154.9 | 14.2 |
Net margin | -2.0% | -5.6% | -6.8% | -18.3% | 18.5% | 11.9% | -35.7% | 2.6% |
|
Basic EPS [+] | ($28.78) | ($2.27) | ($1.60) | ($7.77) | $0.96 | $0.15 | ($2.49) | $0.21 |
Growth | 1167.9% | 42.0% | -79.4% | -907.9% | 526.4% | -106.2% | -1282.6% | 934.6% |
Diluted EPS [+] | ($28.78) | ($2.26) | ($1.59) | ($7.73) | $0.96 | $0.15 | ($2.49) | $0.21 |
Growth | 1171.8% | 42.1% | -79.4% | -908.6% | 530.6% | -106.1% | -1302.6% | 932.6% |
|
Dividends per share [+] | $0.10 | $0.40 | $0.40 | $0.40 | $0.40 | $0.40 | $0.40 | $0.40 |
Growth | -75.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 17.6% |
|
Shares outstanding (basic) [+] | 74.9 | 74.2 | 73.6 | 72.0 | 70.5 | 69.6 | 68.5 | 67.4 |
Growth | 0.9% | 0.9% | 2.2% | 2.1% | 1.3% | 1.6% | 1.6% | 1.1% |
Shares outstanding (diluted) [+] | 74.9 | 74.5 | 73.9 | 72.4 | 70.9 | 70.5 | 68.5 | 68.5 |
Growth | 0.6% | 0.8% | 2.0% | 2.0% | 0.6% | 2.9% | -0.1% | 1.3% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |